Modulation of type IV collagenase and plasminogen activator in a hamster fibrosarcoma by basement membrane components and lung fibroblasts
- PMID: 2840108
- PMCID: PMC2246388
- DOI: 10.1038/bjc.1988.110
Modulation of type IV collagenase and plasminogen activator in a hamster fibrosarcoma by basement membrane components and lung fibroblasts
Abstract
The effect of basement membrane components (laminin, fibronectin and type IV collagen) and lung fibroblasts on type IV collagenase and plasminogen activator activity was investigated in a primary HSV-2-induced hamster fibrosarcoma, and its in vivo derived sublines and in vitro derived clones of varying metastatic potential. Fibronectin and type IV collagen were ineffective at influencing the expression of either type IV collagenase or plasminogen activator activity. Laminin, however, at concentrations of 1-10 micrograms ml-1 added to the serum-free culture supernatants, increased the release of type IV collagenase by up to 100% for the parental cell line. Three highly metastatic sublines (two from in vivo origin and one from in vitro cloning) showed increases of up to 300%. Non-metastatic sublines (two from in vivo origin and one from in vitro cloning), however, showed no increase in type IV collagenase activity. Plasminogen activator release from either the parental line cell or its metastatic sublines and clones, was unaffected by the addition of laminin. Addition of tumour cells to lung fibroblast monolayers resulted in an increased expression of PA activity in the supernatant, whilst type IV collagenase activity was reduced.
Similar articles
-
Type IV collagenase activity of a primary HSV-2-induced hamster fibrosarcoma and its in vivo metastases and in vitro clones.Cancer. 1987 Sep 15;60(6):1263-8. doi: 10.1002/1097-0142(19870915)60:6<1263::aid-cncr2820600617>3.0.co;2-v. Cancer. 1987. PMID: 3040211
-
Production of plasminogen activator by a primary HSV-2-induced hamster fibrosarcoma and its in vivo derived sublines.Cancer. 1986 Apr 15;57(8):1522-7. doi: 10.1002/1097-0142(19860415)57:8<1522::aid-cncr2820570814>3.0.co;2-o. Cancer. 1986. PMID: 3948129
-
Laminin increases the release of type IV collagenase from malignant cells.J Biol Chem. 1986 Feb 5;261(4):1883-9. J Biol Chem. 1986. PMID: 3003087
-
Inhibitors of collagenase IV and cell adhesion reduce the invasive activity of malignant tumour cells.Ciba Found Symp. 1988;141:193-210. doi: 10.1002/9780470513736.ch11. Ciba Found Symp. 1988. PMID: 2855414 Review.
-
Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.J Neurooncol. 1994;18(2):129-38. doi: 10.1007/BF01050419. J Neurooncol. 1994. PMID: 7964975 Review.
Cited by
-
Soluble factors released by the target organ enhance the urokinase-type plasminogen activator activity of metastatic tumor cells.Clin Exp Metastasis. 1991 Jan-Feb;9(1):51-6. doi: 10.1007/BF01831709. Clin Exp Metastasis. 1991. PMID: 2015717
-
Urinary laminin fragments as a tumour marker potentially reflecting basement membrane destruction.Br J Cancer. 1992 Apr;65(4):509-14. doi: 10.1038/bjc.1992.105. Br J Cancer. 1992. PMID: 1562459 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources